DARA Biosciences Cash from Investing Quarterly:
0.7376M for Dec. 31, 2012DARA Biosciences Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 0.7376M |
| Sept. 30, 2012 | -0.242M |
| June 30, 2012 | -0.0107M |
| March 31, 2012 | -0.0255M |
| Dec. 31, 2011 | 0.00 |
| Sept. 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| Dec. 31, 2010 | -0.0027M |
| Sept. 30, 2010 | 0.00 |
| June 30, 2010 | -0.0006M |
| March 31, 2010 | -0.0032M |
| Dec. 31, 2009 | -0.0012M |
| Sept. 30, 2009 | -0.0039M |
| June 30, 2009 | 0.0987M |
| March 31, 2009 | 0.5816M |
| Dec. 31, 2008 | -0.0084M |
| Sept. 30, 2008 | 0.0006M |
| June 30, 2008 | -0.0066M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
DARA Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Cyclacel Pharmaceuticals | 0.00 |
| Prana Biotechnology | |
| Bioline Rx | -12.06M |
DARA Cash from Investing Quarterly Rankings
| Overall |
92nd percentile 606 of 8007 |
| Sector |
88th percentile 76 of 685 in Healthcare |
| Industry |
83rd percentile 41 of 248 in Biotechnology |
DARA Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -0.2420M | Sep 2012 |
| Maximum | 0.7376M | Dec 2012 |
| Average | 0.0586M |
